Common use of Reporting by Translate Bio Clause in Contracts

Reporting by Translate Bio. 6.4.1 Translate Bio shall notify Sanofi in writing in accordance with Section 17.11 (Notices) within [**] of the expiration or termination of any Pre-Existing Agreements or any Future Agreements executed by Translate Bio, and of any material change or amendment to such Pre-Existing Agreements or any Future Agreements executed by Translate Bio which would have a material impact on Sanofi’s rights and obligations herein, including those pursuant to Articles 7 and 9. 6.4.2 Translate Bio shall deliver an annual report to Sanofi by [**] of each year summarizing the Patents claiming Licensed Improvements and also Licensed Improvements which are material improvements comprising Know-How and Materials for the previous year each year until the [**] of the Closing. Following receipt of such report, Sanofi shall notify Translate Bio in writing within [**] if Sanofi wishes to include under Section 9.1.3 exclusive rights to any such Licensed Improvements, which rights are hereby included as of the date on which Translate Bio receives Sanofi’s notice. If Sanofi does not elect to include such rights, Licensed Improvements will cease to be Licensed Improvements under this Agreement. Where such Licensed Improvements are Materials, Sanofi shall reply within such [**] indicating whether it wishes to receive from Translate Bio a quantity of such Materials in those instances where Sanofi cannot create the Materials itself (or through a Service Provider) by using information available publicly or from Translate Bio. In such case, the Parties shall follow the procedure described in Section 3.9 (Transfer of Materials) and Sanofi shall bear the costs associated with the provision of such Materials.